Viewing Study NCT02488967


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-26 @ 1:27 PM
Study NCT ID: NCT02488967
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-03
First Post: 2015-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Sponsor: NRG Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module